{
    "Trade/Device Name(s)": [
        "Glucose Meter-Check\u2122 Control Solution For Bayer Ascensia Blood Glucose Test Systems"
    ],
    "Submitter Information": "Bionostics, Inc.",
    "510(k) Number": "K082395",
    "Predicate Device Reference 510(k) Number(s)": [
        "K062347",
        "K023657",
        "K043311",
        "K023584",
        "K070506"
    ],
    "Regulatory Class": "Class I, Reserved",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "September 18, 2008",
    "Summary Letter Received Date": "August 20, 2008",
    "Submission Date": "August 18, 2008",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [
        "plastic vial"
    ],
    "Instrument(s)/Platform(s)": [
        "Bayer Ascensia Breeze 2",
        "Bayer Ascensia Contour",
        "Bayer Ascensia Elite",
        "Bayer Ascensia DEX 2"
    ],
    "Method(s)/Technology(ies)": [
        "Single analyte control solution"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for Glucose Meter-Check Control Solution for Bayer Ascensia blood glucose test systems as a viscosity-adjusted aqueous glucose control material",
    "Indications for Use Summary": "Intended to assess the performance of Bayer Ascensia Breeze 2, Contour, Elite, and DEX 2 blood glucose test systems; for use by healthcare professionals and people with diabetes mellitus at home",
    "fda_folder": "Clinical Chemistry"
}